Back

Effect of ICD on patients with improved EF in idiopathic dilated cardiomyopathy

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Novel approaches for predicting and treating ventricular arrhythmias Device Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Simrat Dhaliwal

Stony Brook University Hospital, Stony Brook (United States of America)

8 More presentations in this session

Presentation thumbnail
Incidence of sustained ventricular tachyarrhythmias in patients with non-ischemic cardiomyopathy in a multicenter multinational WCD cohort
Doctor J. Erath (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Using the 3D architecture of scar to predict life-threatening ventricular arrhythmias, still a long way to go
Doctor R. Amador (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Integration of electro-anatomical maps in the planning phase of stereotactic arrhythmia radioablation for refractory ventricular tachycardia
Doctor C. Teres (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of ventricular arrhythmias in arrhythmogenic cardiomyopathy - comparison of different approaches and results of genetic testing
Doctor A. Rafaj (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
A valuable electrophysiological insight to distinguish right from left outflow tract ventricular arrhythmia -local activation time in the anterior intraventricular vein and distal great cardiac vein-
Doctor J. Doi (Tsuchiura, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel approaches for predicting and treating ventricular arrhythmias

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Incidence of ventricular arrhythmias in ICD patients after improvement of left ventricular ejection fraction: a longitudinal study
thumbnail
Congress Presentation
When to implant an ICD in patients with heart failure and reduced ejection fraction? Insights from the HF-OPT trial.
thumbnail
Congress Presentation
Heart failure etiology and ARNI + SGLT2i initiation may influence implantable cardioverter-defibrillator implantation timing

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources